Rectal Cancer

  • Quinton Morrow Hatch
  • Eric K. Johnson


Adenocarcinoma of the rectum is a common diagnosis that will be encountered by the majority of practicing general surgeons. It is associated with a complex treatment algorithm that is essential to understand such that we can ensure optimal patient outcome and acceptable locoregional recurrence rates. The treatment paradigm continues to change through active research. It is the purpose of this chapter to provide a basic algorithm for practicing surgeons that will address the majority of patient scenarios. While we do not intend for these recommendations to be prescriptive, they should provide a solid working basis. Of course, there will be scenarios outside the scope of this particular algorithm that could be encountered.


Rectal cancer Rectal adenocarcinoma Locally advanced rectal cancer Neoadjuvant chemoradiotherapy 


  1. 1.
    Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet. 1908;172:1812–3.CrossRefGoogle Scholar
  2. 2.
    Whipple A. Complications associated with major proctectomy. Ann Surg. 1932;95(6):916–22.CrossRefGoogle Scholar
  3. 3.
    Guren MG, et al. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol. 2005;31(7):735–42.CrossRefGoogle Scholar
  4. 4.
    Eveno C, Lamblin A, Mariette C, Pocard M. Sexual and urinary dysfunction after proctectomy for rectal cancer. J Visc Surg. 2010;147(1):e21–30.CrossRefGoogle Scholar
  5. 5.
    Heald RJ. The mesorectum in rectal cancer surgery. Br J Surg. 1982;69:613–6.CrossRefGoogle Scholar
  6. 6.
    Cedermark B, Dahlberg M, Glimelius B, et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–7.CrossRefGoogle Scholar
  7. 7.
    Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.CrossRefGoogle Scholar
  8. 8.
    Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.CrossRefGoogle Scholar
  9. 9.
    Shapiro J, Seeff L, Thompson T, et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2008;17(7):1623–30.CrossRefGoogle Scholar
  10. 10.
    Alexiusdottir K, Moller P, Snaebjornsson P, et al. Association of symptoms of colon cancer patients with tumor location and TNM tumor stage. Scand J Gastroenterol. 2012;47:795–801.CrossRefGoogle Scholar
  11. 11.
    Watson AJ, Shanmugam V, Mackay I, et al. Outcomes after placement of colorectal stents. Color Dis. 2005;7:70–3.CrossRefGoogle Scholar
  12. 12.
    Chia D, Lu J, Zheng H, et al. Efficacy of palliative radiation therapy for symptomatic rectal cancer. Radiother Oncol. 2016;121(2):258–61.CrossRefGoogle Scholar
  13. 13.
    Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985 Aug;89(2):328–36.CrossRefGoogle Scholar
  14. 14.
    Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993;25(7):455–61.CrossRefGoogle Scholar
  15. 15.
    Ramirez M, Schierling S, Papaconstantinou HT, Thomas JS. Management of the malignant polyp. Clin Colon Rectal Surg. 2008;21(4):286–90.CrossRefGoogle Scholar
  16. 16.
    Ferlitsch M, Moss A, Hassan C. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2017;49(03):270–97.CrossRefGoogle Scholar
  17. 17.
    Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and metaanalysis. Ann Surg Oncol. 2012;19:2212–23.CrossRefGoogle Scholar
  18. 18.
    Hari DM, Leung AM, Lee JH, et al. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg. 2013;217(2):181–90.CrossRefGoogle Scholar
  19. 19.
    Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45(2):200–6.CrossRefGoogle Scholar
  20. 20.
    Saraste D, Gunnarsson U, Martin J. Predicting lymph node metastases in early rectal cancer. Eur J Cancer. 2013;49(5):1104–8.CrossRefGoogle Scholar
  21. 21.
    National Comprehensive Cancer Network. Rectal cancer (Version 3.2017). Accessed 25 July 2017.
  22. 22.
    Bujko K, Nowackib MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol. 2004;72:15–24.CrossRefGoogle Scholar
  23. 23.
    Nagtegaal I, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26(2):303–12.CrossRefGoogle Scholar
  24. 24.
    Garcia-Aguilar J, Smith DD, Avila K, et al. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg. 2011;254(1):97–102.CrossRefGoogle Scholar
  25. 25.
    Taylor F, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253:711–9.CrossRefGoogle Scholar
  26. 26.
    van Gijn W, Marijnen C, Nagtegaal I, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575–82.CrossRefGoogle Scholar
  27. 27.
    Pawlik T, Schulick R, Choti M. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51–64.CrossRefGoogle Scholar
  28. 28.
    Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141(5):460–6.CrossRefGoogle Scholar
  29. 29.
    Kemeny N, Huitzil Melendez F, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27(21):3465–71.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Quinton Morrow Hatch
    • 1
  • Eric K. Johnson
    • 2
    • 3
  1. 1.Department of SurgeryMadigan Army Medical CenterTacomaUSA
  2. 2.Cleveland Clinic FoundationClevelandUSA
  3. 3.Department of Surgery, Division of Colorectal SurgeryHillcrest HospitalMayfield HeightsUSA

Personalised recommendations